![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 29, 26480-26487, July 18, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the
Department of Molecular and Medical
Pharmacology, UCLA School of Medicine, Los Angeles, California 90095 and
¶Wolfson Institute for Biomedical Research,
University College London, London WC1E 6AE, United Kingdom
Expression of inducible nitric-oxide (NO) synthase (iNOS) and
"high-output" production of NO by macrophages mediates many
cytotoxic actions of these immune cells. However, macrophages have also been
shown to express a constitutive NOS isoform, the function of which remains
obscure. Herein, bone marrow-derived macrophages (BMDMØs) from
wild-type and endothelial NOS (eNOS) knock-out (KO) mice have been used to
assess the role of this constitutive NOS isoform in the regulation of
macrophage activation. BMDMØs from eNOS KO animals exhibited reduced
nuclear factor-
B activity, iNOS expression, and NO production after
exposure to lipopolysaccharide (LPS) as compared with cells derived from
wild-type mice. Soluble guanylate cyclase (sGC) was identified in
BMDMØs at a mRNA and protein level, and activation of cells with LPS
resulted in accumulation of cyclic GMP. Moreover, the novel non-NO-based sGC
activator, BAY 41-2272, enhanced BMDMØ activation in response to LPS,
and the sGC inhibitor
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one attenuated
activation. These observations provide the first demonstration of a
pathophysiological role for macrophage eNOS in regulating cellular activation
and suggest that NO derived from this constitutive NOS isoform, in part via
activation of sGC, is likely to play a pivotal role in the initiation of an
inflammatory response.
Received for publication, March 4, 2003 , and in revised form, May 6, 2003.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a Wellcome Trust International Prize Traveling Research
Fellowship.
|| Recipient of a Wellcome Trust Senior Fellowship in Basic Biomedical Sciences. To whom correspondence should be addressed: Wolfson Institute for Biomedical Research, University College London, Cruciform Bldg., Gower St., London WC1E 6AE, United Kingdom. Tel.: 44-(0)20-7679-6611; Fax: 44-(0)20-7813-2846; E-mail: a.hobbs{at}ucl.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Ying, A. B. Hofseth, D. D. Browning, M. Nagarkatti, P. S. Nagarkatti, and L. J. Hofseth Nitric Oxide Inactivates the Retinoblastoma Pathway in Chronic Inflammation Cancer Res., October 1, 2007; 67(19): 9286 - 9293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chatterjee, C. Dimitropoulou, F. Drakopanayiotakis, G. Antonova, C. Snead, J. Cannon, R. C. Venema, and J. D. Catravas Heat Shock Protein 90 Inhibitors Prolong Survival, Attenuate Inflammation, and Reduce Lung Injury in Murine Sepsis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Teixeira, F. B. M. Priviero, and R. C. Webb Effects of 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on Smooth Muscle Tone, Soluble Guanylyl Cyclase Activity, and NADPH Oxidase Activity/Expression in Corpus Cavernosum from Wild-Type, Neuronal, and Endothelial Nitric-Oxide Synthase Null Mice J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1093 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Villar, C. M. Panayiotou, A. Sheraz, M. Madhani, R. S. Scotland, M. Nobles, B. Kemp-Harper, A. Ahluwalia, and A. J. Hobbs Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor Cardiovasc Res, June 1, 2007; 74(3): 515 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ying and L. J. Hofseth An Emerging Role for Endothelial Nitric Oxide Synthase in Chronic Inflammation and Cancer Cancer Res., February 15, 2007; 67(4): 1407 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Amico, F. Lam, T. Hagen, and S. Moncada Inhibition of cellular respiration by endogenously produced carbon monoxide J. Cell Sci., June 1, 2006; 119(11): 2291 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gross and Y. Hattori Room for both tyrosine nitration and cysteine nitrosylation to regulate NF{kappa}B activity, but perhaps only one modification at a time Cardiovasc Res, September 1, 2005; 67(4): 747 - 748. [Full Text] [PDF] |
||||
![]() |
G. Thoeni, P. Stoitzner, G. Brandacher, N. Romani, C. Heufler, G. Werner-Felmayer, and E. R. Werner Tetrahydro-4-Aminobiopterin Attenuates Dendritic Cell-Induced T Cell Priming Independently from Inducible Nitric Oxide Synthase J. Immunol., June 15, 2005; 174(12): 7584 - 7591. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Connelly, M. Madhani, and A. J. Hobbs Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice: A PRO-INFLAMMATORY ROLE FOR eNOS-DERIVED NO IN VIVO J. Biol. Chem., March 18, 2005; 280(11): 10040 - 10046. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Vo, B. Lad, J. A. P. Tomlinson, S. Francis, and A. Ahluwalia Autoregulatory Role of Endothelium-derived Nitric Oxide (NO) on Lipopolysaccharide-induced Vascular Inducible NO Synthase Expression and Function J. Biol. Chem., February 25, 2005; 280(8): 7236 - 7243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gilchrist, S. D. McCauley, and A. D. Befus Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production Blood, July 15, 2004; 104(2): 462 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Paul-Clark, T. van Cao, N. Moradi-Bidhendi, D. Cooper, and D. W. Gilroy 15-epi-lipoxin A4-mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation J. Exp. Med., July 6, 2004; 200(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ongini, F. Impagnatiello, A. Bonazzi, M. Guzzetta, M. Govoni, A. Monopoli, P. Del Soldato, and L. J. Ignarro Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties PNAS, June 1, 2004; 101(22): 8497 - 8502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nath, J. Enciso, M. Kuniyasu, X.-Y. Hao, J. A. Madri, and E. Pinter Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy Development, May 15, 2004; 131(10): 2485 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watarai, H. Warita, and K. Soma Effect of Nitric Oxide on the Recovery of the Hypofunctional Periodontal Ligament J. Dent. Res., April 1, 2004; 83(4): 338 - 342. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |